The Column Group is a San Francisco, California–based venture capital firm founded in 2007 that focuses on building and funding early-stage life sciences companies, particularly in drug discovery, biotechnology, pharmaceuticals and related scientific platforms. The firm partners with world-class scientific founders and entrepreneurs to support innovations from inception through later stages, using an edge-to-edge venture-biotech model that integrates capital, expertise and operational guidance. Its approach emphasizes deep scientific rigour and hands-on company formation to translate research into commercial therapeutic ventures and potential breakthroughs. The Column Group manages multiple funds and has backed dozens of biotech ventures, contributing to exits and growth in transformative life science markets.